Viewing Study NCT05207735


Ignite Creation Date: 2025-12-24 @ 10:10 PM
Ignite Modification Date: 2026-01-29 @ 11:53 PM
Study NCT ID: NCT05207735
Status: UNKNOWN
Last Update Posted: 2022-01-26
First Post: 2021-11-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: PD-1 Inhibitor Sintilimab Combined With Capecitabine for Adjuvant Treatment After Radical Resection of Cholangiocarcinoma.
Sponsor:
Organization: